{"id":"https://openalex.org/W3215088282","doi":null,"title":"Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases","display_name":"Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-18","ids":{"openalex":"https://openalex.org/W3215088282","mag":"3215088282"},"language":"en","primary_location":{"id":"mag:3215088282","doi":null,"is_oa":false,"landing_page_url":"https://scholarbank.nus.edu.sg/handle/10635/206736","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Elements","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W3215088282"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090355682","display_name":"Ivan Yu Jun Seah","orcid":"https://orcid.org/0000-0001-7843-1917","observed_orcids":["https://orcid.org/0000-0001-7843-1917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan Seah","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7843-1917","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107657414","display_name":"Xinxin Zhao","orcid":"https://orcid.org/0000-0002-9673-3967","observed_orcids":["https://orcid.org/0000-0002-9673-3967"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinxin Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9673-3967","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055307034","display_name":"Qianyu Lin","orcid":"https://orcid.org/0000-0002-7721-1370","observed_orcids":["https://orcid.org/0000-0002-7721-1370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qianyu Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7721-1370","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065844528","display_name":"Zengping Liu","orcid":"https://orcid.org/0000-0002-2578-293X","observed_orcids":["https://orcid.org/0000-0002-2578-293X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zengping Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012965926","display_name":"Steven Zheng Zhe Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Zheng Zhe Su","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078454310","display_name":"Yew Sen Yuen","orcid":"https://orcid.org/0000-0003-0010-614X","observed_orcids":["https://orcid.org/0000-0003-0010-614X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yew Sen Yuen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054329378","display_name":"Walter Hunziker","orcid":"https://orcid.org/0000-0002-5265-4933","observed_orcids":["https://orcid.org/0000-0002-5265-4933","https://orcid.org/0000-0001-8570-1989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter Hunziker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5265-4933","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091338725","display_name":"Lingam Gopal","orcid":"https://orcid.org/0000-0001-9130-5712","observed_orcids":["https://orcid.org/0000-0001-9130-5712"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingam Gopal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9130-5712","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059594060","display_name":"Xian Jun Loh","orcid":"https://orcid.org/0000-0001-8118-6502","observed_orcids":["https://orcid.org/0000-0001-8118-6502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xian Jun Loh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8118-6502","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5085381416","display_name":"Xinyi Su","orcid":"https://orcid.org/0000-0002-1480-6713","observed_orcids":["https://orcid.org/0000-0002-1480-6713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinyi Su","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1480-6713","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.041200000792741776,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.9929999709129333},{"id":"https://openalex.org/keywords/retinal-disease","display_name":"retinal disease","score":0.8880000114440918},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9660000205039978},{"id":"https://openalex.org/keywords/proliferative-diabetic-retinopathy","display_name":"proliferative diabetic retinopathy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intravitreal-injection-complications","display_name":"intravitreal injection complications","score":0.8199999928474426},{"id":"https://openalex.org/keywords/endophthalmitis","display_name":"endophthalmitis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/posterior-segment-drug-delivery","display_name":"posterior segment drug delivery","score":0.8330000042915344},{"id":"https://openalex.org/keywords/biomaterials","display_name":"biomaterials","score":0.7730000019073486},{"id":"https://openalex.org/keywords/nanoformulations","display_name":"nanoformulations","score":0.7390000224113464},{"id":"https://openalex.org/keywords/hydrogels","display_name":"hydrogels","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7551573514938354},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7521495223045349},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.7496573328971863},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.6547272205352783},{"id":"https://openalex.org/C113520495","wikidata":"https://www.wikidata.org/wiki/Q2359854","display_name":"Posterior segment of eyeball","level":2,"score":0.583541750907898},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5660911202430725},{"id":"https://openalex.org/C2777235844","wikidata":"https://www.wikidata.org/wiki/Q1294912","display_name":"Endophthalmitis","level":2,"score":0.4927683174610138},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.483425498008728},{"id":"https://openalex.org/C2780226545","wikidata":"https://www.wikidata.org/wiki/Q6888030","display_name":"Modality (human\u2013computer interaction)","level":2,"score":0.45308178663253784},{"id":"https://openalex.org/C3020606620","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Treatment modality","level":2,"score":0.4254719018936157},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4197996258735657},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3233329653739929},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.14082729816436768},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.11570000648498535},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C107457646","wikidata":"https://www.wikidata.org/wiki/Q207434","display_name":"Human\u2013computer interaction","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3215088282","doi":null,"is_oa":false,"landing_page_url":"https://scholarbank.nus.edu.sg/handle/10635/206736","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Elements","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3125642895","https://openalex.org/W3217272144","https://openalex.org/W4296720485","https://openalex.org/W4401756191","https://openalex.org/W3013314594","https://openalex.org/W2009072343","https://openalex.org/W2464461682","https://openalex.org/W4280523714","https://openalex.org/W2017169374","https://openalex.org/W2943389110"],"abstract_inverted_index":{"Anti-vascular":[0],"endothelial":[1],"growth":[2],"factors":[3],"(anti-VEGF)":[4],"have":[5,70,116,121],"become":[6],"the":[7,58,77,84,87,106,110,134,140,144,162,170,177,188,198],"most":[8,47],"common":[9],"treatment":[10],"modality":[11],"for":[12,102],"many":[13],"retinal":[14,28,67],"diseases.":[15],"These":[16,124],"include":[17,125],"neovascular":[18],"age-related":[19],"macular":[20],"degeneration":[21],"(n-AMD),":[22],"proliferative":[23],"diabetic":[24],"retinopathy":[25],"(PDR)":[26],"and":[27,129,179],"vein":[29],"occlusions":[30],"(RVO).":[31],"However,":[32],"these":[33,50],"drugs":[34],"are":[35,41],"administered":[36],"via":[37],"intravitreal":[38],"injections":[39,74],"that":[40,120],"associated":[42],"with":[43,60,66,169],"sight-threatening":[44,88],"complications.":[45,89],"The":[46,149],"feared":[48],"of":[49,57,86,109,136,143,151,181,197,206],"complications":[51],"is":[52],"endophthalmitis,":[53],"a":[54],"severe":[55],"infection":[56],"eye":[59,145],"extremely":[61],"poor":[62],"visual":[63],"outcomes.":[64],"Patients":[65],"diseases":[68],"typically":[69],"to":[71,105,139,175,193],"undergo":[72],"multiple":[73],"before":[75],"achieving":[76],"desired":[78],"therapeutic":[79],"effect.":[80],"Each":[81],"injection":[82],"incurs":[83],"risk":[85],"As":[90],"such,":[91],"there":[92,115],"has":[93],"been":[94,117,122],"great":[95],"interest":[96],"in":[97,173,202],"developing":[98],"sustained":[99,154,183,199],"delivery":[100,138,155,185,200],"platforms":[101,201],"anti-VEGF":[103],"agents":[104],"posterior":[107,141],"segment":[108,142],"eye.":[111],"In":[112,131],"recent":[113],"years,":[114],"various":[118,204],"strategies":[119,165],"conceptualised.":[123],"non-biodegradable":[126],"implants,":[127],"nano-formulations":[128],"hydrogels.":[130],"this":[132,190],"review,":[133],"barriers":[135],"drug":[137,184],"will":[146,157,166],"be":[147,159,167],"explained.":[148],"characteristics":[150,172],"an":[152,195],"ideal":[153],"platform":[156],"then":[158],"discussed.":[160],"Finally,":[161],"current":[163],"available":[164],"analysed":[168],"above-mentioned":[171],"mind":[174],"determine":[176],"advantages":[178],"disadvantages":[180],"each":[182],"modality.":[186],"Through":[187],"above,":[189],"review":[191],"attempts":[192],"provide":[194],"overview":[196],"their":[203],"phases":[205],"development.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3215088282","counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2021-12-06T00:00:00"}
